Sarvhit Mediserve Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.00 Cr
- Revenue Growth %
- Ebitda
- Net Worth 400.00%
- Total Assets 383.39%
About Sarvhit Mediserve
Sarvhit Mediserve Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 April 2021 (Three years and nine months 2 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹18.00 Cr.
Naman Shah, Kavita Shah, and Mahesh Shah serve as directors at the Company.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300PN2021PTC200706
-
Company No.
200706
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Apr 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Sarvhit Mediserve?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Shah
|
Director | 30-Apr-2021 | Current |
|
Kavita Shah
|
Director | 30-Apr-2021 | Current |
|
Mahesh Shah
|
Director | 30-Apr-2021 | Current |
Financial Performance of Sarvhit Mediserve.
Sarvhit Mediserve Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 400%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvhit Mediserve?
Unlock access to Sarvhit Mediserve's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹180.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 18.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2022 | Hdfc Bank Limited | ₹18.00 Cr | Open |
How Many Employees Work at Sarvhit Mediserve?
Sarvhit Mediserve has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvhit Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvhit Mediserve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.